Which has grown faster, IDXX or MRNA?

Over the past five years, MRNA grew revenue faster — IDXX at a 8.37% CAGR versus MRNA at 19.33%.

Is IDXX or MRNA more profitable?

IDXX runs the higher net margin — IDXX at 25.03% versus MRNA at -141.43%.

How have IDXX and MRNA total returns compared?

Over the past 5 years, IDXX delivered 17.48% and MRNA delivered -17.63% annualized total return. Past performance doesn't predict future results.

IDEXX Laboratories, Inc. (IDXX) vs Moderna, Inc. (MRNA)

A side-by-side comparison of IDEXX Laboratories, Inc. and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 23, 2026. Differences are shown without an overall score or investment verdict.

IDXX

IDEXX Laboratories, Inc.

$43.93B

$556.93HealthcareAt close: Aug 21, 2026, 4:00 PM ET

MRNA

Moderna, Inc.

$57.59B

$145.13HealthcareAt close: Aug 21, 2026, 4:00 PM ET

Total return — IDXX vs MRNA

growth of $100 · dividends reinvested · last 8y

IDXX +169.9% (+13.2%/yr)MRNA +680.3% (+29.3%/yr)MRNA compounded faster over this window

IDXX MRNA

IDXX vs MRNA: by the numbers

•MRNA is the larger company ($57.59B vs $43.93B market cap).
•IDXX is profitable (25.03% net margin) while MRNA runs a net loss (-141.43%).
•MRNA grew revenue faster over the past five years (19.33% vs 8.37% CAGR).

Metrics side by side

Valuation

Metric	IDXX	MRNA
P/E ratio	39.44	N/A
Forward P/E	37.70	N/A
P/S ratio	9.87	25.80
P/B ratio	27.86	8.50
EV / EBITDA	28.42	N/A
FCF yield	2.78%	N/A

Profitability

Metric	IDXX	MRNA
Gross margin	62.45%	55.35%
Operating margin	32.03%	-158.13%
Net margin	25.03%	-141.43%
ROE	70.67%	-46.61%
ROIC	41.33%	-39.16%

Growth (annualized)

Metric	IDXX	MRNA
Revenue CAGR (5Y)	8.37%	19.33%
EPS CAGR (5Y)	14.07%	N/A
FCF CAGR (5Y)	12.49%	N/A
Total return CAGR (5Y)	-3.97%	-17.63%

Frequently asked

Which has grown faster, IDXX or MRNA?: Over the past five years, MRNA grew revenue faster — IDXX at a 8.37% CAGR versus MRNA at 19.33%.
Is IDXX or MRNA more profitable?: IDXX runs the higher net margin — IDXX at 25.03% versus MRNA at -141.43%.
How have IDXX and MRNA total returns compared?: Over the past 5 years, IDXX delivered 17.48% and MRNA delivered -17.63% annualized total return. Past performance doesn't predict future results.

Go deeper

Full IDXX analysis Full MRNA analysis Interactive comparison tool

Dig into the metrics

IDEXX Laboratories P/E ratio IDEXX Laboratories ROE Moderna ROE IDEXX Laboratories operating margin Moderna operating margin IDEXX Laboratories revenue growth Moderna revenue growth IDEXX Laboratories free cash flow Moderna free cash flow

IDEXX Laboratories & Moderna appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 23, 2026.